49 related articles for article (PubMed ID: 18463144)
21. [Rituximab (Mabthera)--new approach in treatment of rheumatoid arthritis].
Anić B
Reumatizam; 2007; 54(2):72-3. PubMed ID: 18351146
[No Abstract] [Full Text] [Related]
22. Tocilizumab for rheumatoid arthritis.
Drug Ther Bull; 2010 Jan; 48(1):9-12. PubMed ID: 20040568
[TBL] [Abstract][Full Text] [Related]
23. [Levamisole used in rheumatoid arthritis].
Veys EM; Mielants H
Acta Rhumatol; 1979; 3(3):219-30. PubMed ID: 11496645
[No Abstract] [Full Text] [Related]
24. Management of patients with rheumatoid arthritis in Latin America: a consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio De Artritis Reumatoide.
Massardo L; Suárez-Almazor ME; Cardiel MH; Nava A; Levy RA; Laurindo I; Soriano ER; Acevedo-Vázquez E; Millán A; Pineda-Villaseñor C; Galarza-Maldonado C; Caballero-Uribe CV; Espinosa-Morales R; Pons-Estel BA
J Clin Rheumatol; 2009 Jun; 15(4):203-10. PubMed ID: 19502907
[TBL] [Abstract][Full Text] [Related]
25. Consensus statement on the use of rituximab in patients with rheumatoid arthritis.
Smolen JS; Keystone EC; Emery P; Breedveld FC; Betteridge N; Burmester GR; Dougados M; Ferraccioli G; Jaeger U; Klareskog L; Kvien TK; Martin-Mola E; Pavelka K;
Ann Rheum Dis; 2007 Feb; 66(2):143-50. PubMed ID: 17068064
[TBL] [Abstract][Full Text] [Related]
26. Comparative overview of safety of the biologics in rheumatoid arthritis.
Khraishi M
J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
[TBL] [Abstract][Full Text] [Related]
27. Long-term effects of rituximab in rheumatoid arthritis: clinical, biologic, and pharmacogenetic aspects.
Quartuccio L; Lombardi S; Fabris M; Masolini P; Saracco M; Pellerito R; De Vita S
Ann N Y Acad Sci; 2009 Sep; 1173():692-700. PubMed ID: 19758217
[TBL] [Abstract][Full Text] [Related]
28. [Rituximab (Mabthera)--treatment of rheumatoid arthritis patients with inadequate response to TNF inhibitors--when to change therapy?].
Morović-Vergles J
Reumatizam; 2008; 55(2):70-2. PubMed ID: 19024280
[TBL] [Abstract][Full Text] [Related]
29. First Latin American position paper on the pharmacological treatment of rheumatoid arthritis.
Cardiel MH; ;
Rheumatology (Oxford); 2006 Jun; 45 Suppl 2():ii7-ii22. PubMed ID: 16709584
[TBL] [Abstract][Full Text] [Related]
30. Vitaxin applied molecular evolution.
Mikecz K
Curr Opin Investig Drugs; 2000 Oct; 1(2):199-203. PubMed ID: 11249574
[TBL] [Abstract][Full Text] [Related]
31. Should rheumatoid arthritis be treated conservatively or aggressively?
Breedveld FC
Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii41-3. PubMed ID: 12817095
[No Abstract] [Full Text] [Related]
32. Rituximab in lupus and beyond: the state of the art.
Hughes G
Lupus; 2009 Jun; 18(7):639-44. PubMed ID: 19433465
[No Abstract] [Full Text] [Related]
33. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
Baslund B; Bendtzen K
Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
[TBL] [Abstract][Full Text] [Related]
34. [Today's strategy for treatment of rheumatoid arthritis].
Kashiwazaki S; Yamanaka H; Matsuda Y
Ryumachi; 1996 Oct; 36(5):791-802. PubMed ID: 8969560
[No Abstract] [Full Text] [Related]
35. Total ankle replacement for rheumatoid ankle arthritis.
Wood PL; Crawford LA; Suneja R; Kenyon A
Foot Ankle Clin; 2007 Sep; 12(3):497-508, vii. PubMed ID: 17765841
[TBL] [Abstract][Full Text] [Related]
36. Another DMARD option in rheumatoid arthritis?
Capell HA; Madhok R
J Rheumatol; 2003 Oct; 30(10):2085-7. PubMed ID: 14528497
[No Abstract] [Full Text] [Related]
37. Biologic agents for treating rheumatoid arthritis. Concepts and progress.
Moreland LW; Heck LW; Koopman WJ
Arthritis Rheum; 1997 Mar; 40(3):397-409. PubMed ID: 9082924
[No Abstract] [Full Text] [Related]
38. [Leflunomide (Arava) in the treatment of rheumatoid arthritis].
Kaliterna DM
Reumatizam; 2007; 54(2):67-8. PubMed ID: 18351143
[No Abstract] [Full Text] [Related]
39. Does sex of rheumatoid arthritis patients matter?
Boers M
Lancet; 1998 Aug; 352(9126):419-20. PubMed ID: 9708746
[No Abstract] [Full Text] [Related]
40. The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing.
Landewé RB
Arthritis Rheum; 2003 Jan; 48(1):1-5. PubMed ID: 12528097
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
